Maximus Berger
Affiliations: | 2015- | Lab. of Psychiatric Neuroscience | JCU |
Google:
"Maximus Berger"Mean distance: 15.65 (cluster 7) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Amminger GP, Lin A, Kerr M, et al. (2021) Cannabidiol for at risk for psychosis youth: A randomized controlled trial. Early Intervention in Psychiatry |
| McLaverty A, Allott KA, Berger M, et al. (2020) Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis. Early Intervention in Psychiatry |
| Berger M, Amminger GP, McDermott R, et al. (2020) Testing the Effects of Dietary Seafood Consumption on Depressive Symptoms. Methods in Molecular Biology (Clifton, N.J.). 2138: 233-242 |
| Ketheesan S, Rinaudo M, Berger M, et al. (2020) Stress, Allostatic Load and Mental Health in Indigenous Australians. Stress (Amsterdam, Netherlands). 1-26 |
| Berger M, Burkhardt E, Yung A, et al. (2020) M22. IGG ANTIBODIES TO TOXOPLASMA GONDII ARE ASSOCIATED WITH INCREASED LONG-TERM RISK FOR PSYCHOSIS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 46: S141-S142 |
| Schlögelhofer M, McGorry PD, Nelson B, et al. (2020) T34. THE IMPACT OF ANTIDEPRESSANT USE ON THE TRANSITION TO PSYCHOSIS RATE IN THE NEURAPRO TRIAL Schizophrenia Bulletin. 46: S244-S245 |
| Hartmann JA, Schmidt SJ, McGorry PD, et al. (2019) Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial. Behaviour Research and Therapy. 124: 103527 |
| Amminger GP, Nelson B, Markulev C, et al. (2019) The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis. Biological Psychiatry |
| Alqarni A, Mitchell TW, McGorry PD, et al. (2019) Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis. Schizophrenia Research |
| Alqarni A, Mitchell TW, McGorry PD, et al. (2019) Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people. Schizophrenia Research |